When we feel pain in response to harmful stimuli it is the result of messages sent from pain sensors in the periphery of the body to the brain. These pain sensors or nociceptors often lie beneath the skin and detect and signal the presence of tissue-damaging stimuli or the existence of tissue damage. One particular nociceptor, vanilloid receptor-1 (VR1), relays sensory messages to the brain in response to thermal and painful chemical stimuli and is generally regarded as the major pain sensor.

In conditions such as arthritis or infection, the tissue involved at these sites becomes acidic. While normal human tissue has a neutral pH of approximately 6.5 - 7.5 (similar to water), tissue acidosis can cause a drop in cellular pH below 6.0 closer to that of household vinegar. When the cellular environment becomes acidic, both VR1 and a second nociceptor - acid sensing ion channels (ASICs) - are activated. In previous experiments in mice, scientists have found that the activation of VR1 requires extremely severe acidification - pH less than 6.0. This suggests that another pain sensor plays a role in nociception, specifically at pH levels greater than 6.0. Despite experimental data revealing that mouse neurons lacking ASICs are severely deficient in their responses to acidic stimuli, controversy remains about the function of ASICs in mammals.

In a study reported in the October 21 issue of the Journal of Clinical Investigation (JCI) by Shinya Ugawa and colleagues from the Nagoya City University Medical School, Japan, the authors demonstrated that both VR1 and ASICs are involved in the sensing of acid-evoked pain in humans and that each type of nociceptor mediates this pain perception at very specific pH ranges. The authors infused solutions of varying pH levels under the skin of the underside of the upper forearm of healthy male volunteers who were subsequently asked to estimate the intensity of the induced pain on a 0-10 scale. To determine which particular
'"/>

Contact: Brooke Grindlinger, PhD
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
22-Oct-2002

Page: 1 2
Related medicine news :

1. Celecoxib shows surprising activity against estrogen receptors
2. Brains nicotine receptors also target for anti-depressants
3. Zengens new study reviews novel approach to control inflammation using melanocortin receptors
4. New compound that acts on peripheral receptors may be treatment for some nerve pain
5. Pattern recognition receptors on mast cells
6. A peptide whose absence leads to narcolepsy also might play role in pain sensation